• Consider genetic manipulation to model particular aspects of human TBI, such as humanized tau or TDP-43 to reliably recapitulate TBI-dependent proteinopathy or APOE genotype to incorporate the risk of poor recovery post-TBI. Here, APOE is linked to proteostasis deficiencies.